info icon

This is a non-core endpoint: only basic statistics are computed.

Progressive external ophthalmoplegia

H7_PROGEXTOPHTHALMOPLEGIA

progressive external ophthalmoplegia: A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. (From Adams et al., Principles of Neurology, 6th ed, p1422)

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 H49.4
Cause of death: ICD-10 H49.4

2 out of 7 registries used, show all original rules.

20

diagram downward connector

Check minimum number of events None

20

diagram downward connector

Include endpoints None

20

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

19

diagram downward connector
H7_PROGEXTOPHTHALMOPLEGIA

Control definitions

Control exclude H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 H49
Name in latin Ophthalmoplegia externa progressiva

Summary Statistics

Key figures

All Female Male
Number of individuals 19 12 7
Unadjusted prevalence (%) 0.00 0.01 0.00
Mean age at first event (years) 49.92 50.59 48.78

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: H7_PROGEXTOPHTHALMOPLEGIA – Progressive external ophthalmoplegia
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Progressive external ophthalmoplegia

Endpoint not on priority list, no data to show.